Fibrosis

Eurofins Discovery’s integrated team of scientists has deep expertise in chronic inflammatory diseases and fibrosis. Fibrosis is a pathological process of wound healing gone awry, intimately correlated with inflammation, and prevents normal function of the affected organ or tissue. Our team has a proven track record of working with clients to aid their discovery of multiple preclinical candidates in this area.
 
To battle these threats to human health, we developed our BioMAP^® Platform. BioMAP– with panel and individual cell-based disease model options and validated with clinical drugs – to accelerate discovery of fibrosis therapies and complements our extensive portfolio of validated in vitro assays and in vivo efficacy models.
 
This unique offering makes Eurofins Discovery your preferred partner at every stage of your fibrosis research and drug discovery programs by designing and implementing solutions that are precisely tailored to your needs and expectations.